# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-21-040093
Filing Date
2021-03-23
Accepted
2021-03-23 10:06:40
Documents
28
Period of Report
2021-03-23
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm2110588d1_8k.htm | 8-K | 21841
2 | EXHIBIT 99.1 | tm2110588d1_ex99-1.htm | EX-99.1 | 32242
3 | GRAPHIC | tm2110588d1_ex99-1img001.jpg | GRAPHIC | 239726
4 | GRAPHIC | tm2110588d1_ex99-1img002.jpg | GRAPHIC | 252677
5 | GRAPHIC | tm2110588d1_ex99-1img003.jpg | GRAPHIC | 206325
6 | GRAPHIC | tm2110588d1_ex99-1img004.jpg | GRAPHIC | 205332
7 | GRAPHIC | tm2110588d1_ex99-1img005.jpg | GRAPHIC | 141181
8 | GRAPHIC | tm2110588d1_ex99-1img006.jpg | GRAPHIC | 197788
9 | GRAPHIC | tm2110588d1_ex99-1img007.jpg | GRAPHIC | 160492
10 | GRAPHIC | tm2110588d1_ex99-1img008.jpg | GRAPHIC | 217957
11 | GRAPHIC | tm2110588d1_ex99-1img009.jpg | GRAPHIC | 197628
12 | GRAPHIC | tm2110588d1_ex99-1img010.jpg | GRAPHIC | 338578
13 | GRAPHIC | tm2110588d1_ex99-1img011.jpg | GRAPHIC | 181466
14 | GRAPHIC | tm2110588d1_ex99-1img012.jpg | GRAPHIC | 226713
15 | GRAPHIC | tm2110588d1_ex99-1img013.jpg | GRAPHIC | 135647
16 | GRAPHIC | tm2110588d1_ex99-1img014.jpg | GRAPHIC | 176821
17 | GRAPHIC | tm2110588d1_ex99-1img015.jpg | GRAPHIC | 161267
18 | GRAPHIC | tm2110588d1_ex99-1img016.jpg | GRAPHIC | 310386
19 | GRAPHIC | tm2110588d1_ex99-1img017.jpg | GRAPHIC | 175516
20 | GRAPHIC | tm2110588d1_ex99-1img018.jpg | GRAPHIC | 201954
21 | GRAPHIC | tm2110588d1_ex99-1img019.jpg | GRAPHIC | 189134
22 | GRAPHIC | tm2110588d1_ex99-1img020.jpg | GRAPHIC | 115768
23 | GRAPHIC | tm2110588d1_ex99-1img021.jpg | GRAPHIC | 161899
24 | GRAPHIC | tm2110588d1_ex99-1img022.jpg | GRAPHIC | 323731
25 | GRAPHIC | tm2110588d1_ex99-1img023.jpg | GRAPHIC | 295670
26 | GRAPHIC | tm2110588d1_ex99-1img024.jpg | GRAPHIC | 240430
27 | GRAPHIC | tm2110588d1_ex99-1img025.jpg | GRAPHIC | 186338
28 | GRAPHIC | tm2110588d1_ex99-1img026.jpg | GRAPHIC | 365224
| Complete submission text file | 0001104659-21-040093.txt |  | 7780190

Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39202 | Film No.: 21763402
SIC: 2834 Pharmaceutical Preparations